DICE Therapeutics, Inc. Profile Avatar - Palmy Investing

DICE Therapeutics, Inc.

DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulat…
Biotechnology
US, South San Francisco [HQ]
Lobbying · US Senate · Influence

Lobbying Analysis

DICE Therapeutics, Inc. has no lobbying expenses in our database.
FY Quarter Lobby Expense [in mil. $] Filing Report Time
No data
End of DICE's Analysis
CIK: 1645569 CUSIP: 23345J104 ISIN: US23345J1043 LEI: - UEI: -
Secondary Listings
DICE has no secondary listings inside our databases.